Get the Stockscreener App
5.04
5.08%
-0.27
Dna X Inc stock is traded at $5.04, with a volume of 54,808.
It is down -5.08% in the last 24 hours and up +2.54% over the past month.
DNA X Inc operates a digital asset management platform.
See More
Previous Close:
$5.31
Open:
$5.35
24h Volume:
54,808
Relative Volume:
1.07
Market Cap:
$7.50M
Revenue:
$57.92M
Net Income/Loss:
$-31.14M
P/E Ratio:
-0.906
EPS:
-5.5628
Net Cash Flow:
$-19.56M
1W Performance:
-8.53%
1M Performance:
+2.54%
6M Performance:
-52.70%
1Y Performance:
-85.71%
1-Day Range:
$4.95
$5.4725
1-Week Range:
$4.95
$5.65
52-Week Range:
$2.5211
$61.00
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
5.04 | 7.90M | 57.92M | -31.14M | -19.56M | -5.5628 |
|
MSFT
Microsoft Corporation
|
405.20 | 3.00T | 305.45B | 119.26B | 77.41B | 15.98 |
|
ORCL
Oracle Corp
|
152.37 | 428.27B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
PLTR
Palantir Technologies Inc
|
153.19 | 352.10B | 4.48B | 1.63B | 2.10B | 0.6328 |
|
CRWD
Crowdstrike Holdings Inc
|
407.68 | 98.68B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
430.98 | 81.28B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How DNA's Double Helix Structure Was Discovered - Britannica
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore
Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan
1 Main Capital exits Sonim Technologies (SONM) with 0.0% ownership - Stock Titan
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNA X, Inc. Appoints Mike Mulica as Acting Chief Executive Officer, Effective February 9, 2026 - marketscreener.com
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks
Leadership shake-up at DNA X (NASDAQ: SONM) as CEO exits and investor designee joins board - Stock Titan
Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan
Will Sonim Technologies Inc. stock outperform value stocksJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru
Best Tech Penny Stocks Right Now • Updated Daily - Benzinga
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - IT Business Net
Five reasons to go rugged in public safety: Sonim Technologies on building phones for fireground realties - International Fire & Safety Journal
Sonim Technologies rebrands as DNA X following asset sale to NEXA - Investing.com Nigeria
Sonim Technologies Rebrands as DNA X, Shifts Strategy - TipRanks
DNA X Signs Asset Purchase Agreement Amendment and Terminates Streeterville Notes - TradingView
Sonim sells assets, rebrands as DNA X running digital asset platform - stocktitan.net
EPS Watch: Is Sonim Technologies Inc exposed to currency risksMarket Trend Review & Entry Point Confirmation Signals - baoquankhu1.vn
Market Wrap: Is Sonim Technologies Inc affected by consumer sentimentWeekly Stock Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Sonim Technologies : NEXA Completes Acquisition of Sonim - marketscreener.com
Sonim Technologies : News Release - marketscreener.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note - Nasdaq
Sonim Technologies (SONM) Projected to Post Earnings on Friday - Defense World
Volatility Watch: Should value investors consider Sonim Technologies IncWeekly Trade Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Sentiment Review: What is the Moat Score of Sonim Technologies IncJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Portfolio Recap: What are the risks of holding Sonim Technologies IncJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Whats the fair value of Sonim Technologies Inc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Resistance Check: Will Sonim Technologies Inc benefit from seasonalityWeekly Trade Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products - Business Wire
Quarterly Trades: Is Sonim Technologies Inc affected by consumer sentimentWeekly Trend Recap & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Inflation Data: Can Sonim Technologies Inc stock hit analyst price targets2025 Key Highlights & Reliable Intraday Trade Plans - Bộ Nội Vụ
Options Flow: Will Sonim Technologies Inc stock outperform tech sector in 2025Stop Loss & Low Risk Growth Stock Ideas - Bộ Nội Vụ
Inflation Data: Will Sonim Technologies Inc. stock outperform tech sector in 2025Treasury Yields & Daily Entry Point Trade Alerts - Bộ Nội Vụ
VIX Spike: Why Sonim Technologies Inc. stock is favored by top institutionsProfit Target & Daily Volume Surge Trade Alerts - Bộ Nội Vụ
Is Sonim Technologies Inc. (6RO) stock overpriced at current multiplesChart Signals & Low Drawdown Trading Strategies - ulpravda.ru
Loss Report: How Sonim Technologies Inc stock performs in weak economyWeekly Stock Recap & Daily Entry Point Trade Alerts - Bộ Nội Vụ
Will Sonim Technologies Inc. (2W9) stock boost dividends further2025 Investor Takeaways & High Yield Stock Recommendations - Улправда
Can Sonim Technologies Inc. stock maintain growth trajectoryEarnings Overview Summary & Accurate Buy Signal Alerts - Улправда
Market Recap: How rising interest rates impact Sonim Technologies Inc. stock2025 Market WrapUp & AI Powered Buy and Sell Recommendations - Улправда
How rising interest rates impact Sonim Technologies Inc. stockQuarterly Portfolio Summary & Precise Trade Entry Recommendations - Улправда
How Sonim Technologies Inc. stock valuations compare to rivalsMomentum Trading Signals & Market Trend Real-Time Reports - ulpravda.ru
The Truth About Myriad Genetics Inc: Is This DNA Stock a Sleeper Goldmine or Just Overhyped? - AD HOC NEWS
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):